España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
iShares U.S. Pharmaceutical ETF
IHE
ARCA
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$66.59
-3.61
-5.14%
Pre-Market: Jan 23, 9:29 AM EDT
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for iShares U.S. Pharmaceutical ETF (ARCA:IHE)
iShares U.S. Pharmaceutical ETF (ARCA: IHE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 24, 2025
Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery
Vandana Singh
Thursday, December 19, 2024
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Vandana Singh
Friday, December 13, 2024
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares
Pooja Rajkumari
Wednesday, November 13, 2024
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'
Vandana Singh
Thursday, November 07, 2024
Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr.
Shivdeep Dhaliwal
Wednesday, August 14, 2024
Pharma ETFs in Focus Post Solid Q2 Earnings
Zacks
Thursday, May 09, 2024
A Look at Pharma ETFs Post Q1 Earnings
Zacks
Tuesday, April 30, 2024
April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
Piero Cingari
Monday, February 26, 2024
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors
Neil Dennis
Tuesday, January 09, 2024
Bank Of America Predicts 10 2024 Market Surprises: From Booming IPOs To Japanese Equity Surge
Piero Cingari
Sunday, November 05, 2023
Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest
Bibhu Pattnaik
Thursday, August 10, 2023
Supreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits Challenged
Michael Cohen
Wednesday, November 09, 2022
5 ETFs To Watch After 2022 Midterm Elections: Which Sectors Win From Republican Or Democrat Majority?
Chris Katje
Monday, May 06, 2019
From Sohn Conference: Larry Robbins Recommend...
Benzinga Newsdesk
Thursday, November 09, 2017
Pharma ETFs Down Post Q3 Earnings
Benzinga
Monday, July 10, 2017
What Lies Ahead For Pharma ETFs In Second Half 2017
Benzinga
Wednesday, November 09, 2016
Last Night's Election - A Series Of Fortunate Events For Big Pharma
Benzinga
Monday, October 10, 2016
Looking For ETF Dogs That Will Hunt
Benzinga
Tuesday, September 27, 2016
Getting Into The Drug Business: From NDAs To PDUFA Dates
Benzinga
Friday, May 27, 2016
Government Study: Cellphone Radiation Linked To Cancer
Benzinga
Monday, November 02, 2015
ETF Week Ahead Preview: Hoping For No November Rain
Benzinga
Thursday, October 29, 2015
These ETFs Should Love The Pfizer-Allergan News
Benzinga
Tuesday, March 03, 2015
February's Best And Worst ETFs
Benzinga
Wednesday, October 22, 2014
Drug ETFs Attractive Buys On Pullback
Benzinga
Tuesday, July 15, 2014
Johnson & Johnson, Goldman Sachs Pushing These ETFs Upward
Benzinga
Tuesday, April 29, 2014
ETF Outlook For Tuesday, April 29, 2014 (IHE, TAN, XRT, SOCL, TWTR)
Benzinga
Friday, April 25, 2014
3 Ways To Profit From Merger Activity In The Pharmaceutical Sector
Benzinga
Tuesday, April 22, 2014
Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)
Benzinga
ETF Outlook For Tuesday, April 22, 2014 (PBS, IHE, IYT, EIRL, VRX, AGN, NFLX)
Benzinga
Monday, March 17, 2014
ETF Outlook For The Week Of March 17, 2014 (EWJ, SPY, IHE, SKYY, ZNGA)
Benzinga
Thursday, February 20, 2014
Pharma ETFs On The Move Again (IHE, PJP, PPH, ACT, FRX)
Benzinga
Wednesday, February 19, 2014
ETF Outlook For Wednesday February 19, 2014 (IHE, BJK, TLT, KWEB)
Benzinga
Wednesday, January 08, 2014
Sector ETFs Breaking Out (IBB, IHE, XLV, IAT, SKYY)
Benzinga
Tuesday, December 17, 2013
Oversold ETFs Looking Attractive (IHE, CSD, PSCE)
Benzinga
Friday, November 08, 2013
ETF Outlook for Friday, November 8 (FIW, XLY, EWQ, DIS, IHE)
Benzinga
Tuesday, October 15, 2013
ETF Outlook for October 15, 2013 (IHE, ITB, EWZ, SMH)
Benzinga
Wednesday, October 02, 2013
Pharmaceutical Industry Expected To Collect Billions From Obamacare
Benzinga
Friday, August 02, 2013
S&P: Heaping Praise For Some Health Care ETFs
Benzinga
Three Soaring, But Overlooked Health Care ETFs
Benzinga
Monday, March 25, 2013
This Dead Money Sector is Leading the S&P This Year
Benzinga
Tuesday, June 19, 2012
Top 10 Healthcare ETFs
Benzinga
Tuesday, May 29, 2012
Trading the European Headline Fiasco (FXE, UUP, SPY, EZU, BUND, IHE)
Benzinga
Thursday, April 19, 2012
S&P: Bullish On Pharma ETFs Long-Term
Benzinga
Wednesday, January 04, 2012
S&P Still Likes Pharma, Staples, Utilities ETFs
Benzinga
Thursday, December 15, 2011
No Surprise Here: Global Stocks Pressuring Sector ETFs, S&P Says
Benzinga
Friday, November 04, 2011
S&P Highlights Some of 2011's Top-Performing ETFs
Benzinga
Monday, October 31, 2011
A Look at The New DRGS ETN
Benzinga
Thursday, October 06, 2011
Bristol-Myers and Quidel to Open Near 52-Week Highs
Benzinga
Monday, August 15, 2011
Perrigo Earnings Preview
Benzinga
Monday, July 25, 2011
Ratchet Back The Risk With These ETFs
Benzinga
Show More
